PharmaCann Penn Plant LLC, a PharmaCann Company, has purchased 18.28 acres of land from SLIBCO, the Scranton Lackawanna Industrial Building Company. The tract is located at Life Science Drive in the Scott Technology Park and will be used to construct a 36,000 square-foot, state-of-the-art pharmaceutical-grade medical marijuana growing and processing facility in accordance with Pennsylvania state regulations. PharmaCann Penn Plant LLC received a license in July 2018 during the second phase of the Pennsylvania Medical Marijuana program.
“The long-standing focus of the Scott Technology Park has been to nurture businesses at the cutting edge of their respective fields,” said Bob Durkin, president, The Greater Scranton Chamber of Commerce. “PharmaCann is doing just that by employing a team of highly skilled professionals both attracted to and drawn from our local talent pool.”
The Scott Technology Park currently has five buildings totaling 201, 520 square feet, with businesses employing 787 people. SLIBCO would like to thank Scott Township, the Lakeland School District and the Lackawanna County Commissioners for their assistance in extending the land’s KOZ permit to 2024.
Founded in 2014, PharmaCann is the largest vertically-integrated and unified medical cannabis company, with four dispensaries and two cultivation facilities in Illinois, where it is the largest holder of medical cannabis licenses, and four dispensaries and one cultivation facility in New York, where it has been awarded the highest-ranked license. With more than 160 professionals, eight dispensaries and three cultivation sites, PharmaCann is focused on growth and pursuing emerging market opportunities every day, including researching opportunities in new states and for new licenses. PharmaCann was purchased in 2018 by MedMen Enterprises, a publicly-traded United States cannabis company, owning and operating 19 cannabis facilities in cultivation, manufacturing and retail.